Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

54 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 7, 2024Oct 7 9:33 PMMelissa Baird
Proposed Sale
58,750$19.44$1.1M

View →

Oct 1, 2024Oct 1 6:35 PMBoughton Soleil
Proposed Sale
2,339$18.50$43.3K

View →

Sep 20, 2024Sep 20 8:34 PMAndrew Dudum
Proposed Sale
687,498$16.92$11.6M

View →

Sep 17, 2024Sep 17 4:38 PMBoughton Soleil
Proposed Sale
2,339$16.50$38.6K

View →

Sep 17, 2024Sep 17 2:59 PMBecklund Irene
Proposed Sale
10,017$16.50$165.3K

View →

Sep 17, 2024Sep 17 2:57 PMChi Michael
Proposed Sale
25,550$16.50$421.6K

View →

Sep 16, 2024Sep 16 2:53 PMBecklund Irene
Proposed Sale
472$16.45$7.8K

View →

Sep 5, 2024Sep 5 9:22 PMMelissa Baird
Proposed Sale
11,749$14.43$169.5K

View →

Sep 4, 2024Sep 4 10:27 PMMelissa Baird
Proposed Sale
11,749$14.61$171.7K

View →

Sep 3, 2024Sep 3 9:18 PMOluyemi Okupe
Proposed Sale
371,177$14.50$5.4M

View →

Sep 3, 2024Sep 3 9:18 PMMelissa Baird
Proposed Sale
11,884$14.50$172.3K

View →

Sep 3, 2024Sep 3 9:18 PMAndrew Dudum
Proposed Sale
333,332$14.50$4.8M

View →

Sep 3, 2024Sep 3 4:13 PMBoughton Soleil
Proposed Sale
2,345$14.65$34.4K

View →

Aug 27, 2024Aug 27 3:09 PMPendarvis Christiane
Proposed Sale
7,000$15.15$106.1K

View →

Nov 6, 2024Carroll Patrick Harrison
Proposed Sale
15,000$22.07$331.1K

View →

← Previous

Page 9 of 9

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 3 of 3